0000903514-19-000008.txt : 20191114 0000903514-19-000008.hdr.sgml : 20191114 20191113174031 ACCESSION NUMBER: 0000903514-19-000008 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191114 DATE AS OF CHANGE: 20191113 EFFECTIVENESS DATE: 20191114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Svennilson Peter CENTRAL INDEX KEY: 0001606074 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16412 FILM NUMBER: 191215517 MAIL ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001606074 XXXXXXXX 09-30-2019 09-30-2019 Svennilson Peter
1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
13F HOLDINGS REPORT 028-16412 N
Peter Svennilson Managing Partner of The Column Group GP, LP and affiliates 4158652050 /s/ Peter Svennilson San Francisco CA 11-13-2019 3 8 321765 false 1 0001600420 028-19198 COLUMN GROUP II, LP 2 0001645333 028-19199 Column Group II GP, LP 3 0001182464 028-16413 GOEDDEL DAVID V
INFORMATION TABLE 2 tcg93019.xml ARCUS BIOSCIENCES INC COM 03969F109 27941 3070423 SH OTR 1, 2, 3 0 3070423 0 ARCUS BIOSCIENCES INC COM 03969F109 4281 470427 SH OTR 3 0 470427 0 CONSTELLATION PHARMCETICLS I COM 210373106 16504 2554850 SH OTR 3 0 2554850 0 CONSTELLATION PHARMCETICLS I COM 210373106 22318 3454852 SH OTR 3 0 3454852 0 GRITSTONE ONCOLOGY INC COM 39868T105 26809 3102934 SH OTR 1, 2, 3 0 3102934 0 NGM BIOPHARMACEUTICALS INC COM 62921N105 31381 2265758 SH OTR 1, 2, 3 0 2265758 0 NGM BIOPHARMACEUTICALS INC COM 62921N105 156551 11303333 SH OTR 3 0 11303333 0 NGM BIOPHARMACEUTICALS INC COM 62921N105 35980 2597816 SH OTR 3 0 2597816 0